Description
BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12
First action · last action
2023-10-02 · 2025-01-15
Transactions
3
First transaction's obligation
$500,000
Base + all options value (sum of deltas)
$611,722
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25221D0073
NAICS
325414 · BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2023-10-02+$500,000= $500,000
- Mod P000012024-07-03+$215,000= $715,000
- Mod P000022025-01-15-$103,278= $611,722
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2023-10-02 | +$500,000 | $500,000 | BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-07-03 | +$215,000 | $715,000 | BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2025-01-15 | −$103,278 | $611,722 | BLOOD AND BLOOD PRODUCTS FOR VHA VISN 12 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JZDRNT166LE4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226N0039 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $750,000 | FY2026 |
| 36C25226N0044 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $302,500 | FY2026 |
| 36C25226N0036 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $460,000 | FY2026 |
| 36C25226N0038 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $15,000 | FY2026 |
| 36C25226N0043 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $560,000 | FY2026 |
| 36C25226N0069 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $900,000 | FY2026 |
Other recipients under 6505 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226N0549 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $170 | FY2026 |
| 36C25226N0550 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,500 | FY2026 |
| 36C25226N0551 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $2,100 | FY2026 |
| 36C25226N0548 | AMERICAN NATIONAL RED CROSS, THE | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $10,000 | FY2026 |
| 36C25226N0450 | BOSTON SCIENTIFIC CORP | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $607,804 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25224N0023_3600_36C25221D0073_3600 · retrieved 2026-09-26.